Detailed answers about 4 MEDICINAL PURPOSES LIMITED, including incorporation, status, business activity, and accounts information.
When was 4 MEDICINAL PURPOSES LIMITED founded?
4 MEDICINAL PURPOSES LIMITED was officially incorporated on 24 June 2025 and is registered under company number 16539271. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is 4 MEDICINAL PURPOSES LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of 4 MEDICINAL PURPOSES LIMITED?
4 MEDICINAL PURPOSES LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does 4 MEDICINAL PURPOSES LIMITED do?
4 MEDICINAL PURPOSES LIMITED operates in the following sectors: 47749 - Retail sale of medical and orthopaedic goods in specialised stores (not incl. hearing aids) n.e.c., 72110 - Research and experimental development on biotechnology, 86220 - Specialists medical practice activities, 86900 - Other human health activities. These SIC codes provide insight into the company's business activities and industry focus.
What is 4 MEDICINAL PURPOSES LIMITED's registered address?
The registered office address of 4 MEDICINAL PURPOSES LIMITED is GRANGE HOUSE, GRANGE ROAD, MIDHURST, WEST SUSSEX, UNITED KINGDOM, GU29 9LS. This is the official address filed with Companies House for legal and statutory correspondence.
Is 4 MEDICINAL PURPOSES LIMITED financially stable?
Financial accounts for 4 MEDICINAL PURPOSES LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.